Andrew R Clamp
6PUBLICATIONS
71CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 16, 2024
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.Robert D Morgan, Xin Wang, Bethany M Barnes
|May 09, 2024
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.Alexander D Murphy, Catharine Porter, Ann White
|Aug 15, 2023
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer.Rachel N Grisham, Ignace Vergote, Susana Banerjee
|Apr 18, 2023
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.Robert D Morgan, Andrew R Clamp, Bethany M Barnes
|Feb 17, 2023
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial.Robert D Morgan, Andrew R Clamp, Daniel J White
|Sep 18, 2020
Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial.Elizabeth C James, David Dunn, Adrian D Cook
Pageof 1
Frequent Collaborators
4 joint publications
Gordon C Jayson
4 joint publications
Robert D Morgan
3 joint publications
D Gareth R Evans
2 joint publications
Susana Banerjee
2 joint publications
Richard J Edmondson
2 joint publications
Reem D Mahmood
2 joint publications
George J Burghel
1 joint publications
Stephen S Taylor
1 joint publications
Elsa Kalbacher
1 joint publications
Mansoor Raza Mirza
